An international collaboration between four scientists from Mainz, Valencia, Madrid, and Zurich has published new research in ...

BOSTON and LONDON, April 16, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody drug conjugates (ADC) ...

With this innovation, the algorithm for searching for new proteins rapidly reduced its computational complexity, becoming non-linear through the spliceosome and the nucleus, which separated ...

This transcript is altered during splicing when specific portions are eliminated by the spliceosome, a cellular editing complex. This results in different blueprints for different proteins ...

With these funds the Company will focus on investing in its novel spliceosome inhibitor payl On-demand video webcast now available here BOSTON and LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE ...